Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.07B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$994M |
| 4 |
CRWV
CoreWeave
CRWV
|
+$858M |
| 5 |
Broadcom
AVGO
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$851M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$700M |
| 3 |
Columbia Research Enhanced Core ETF
RECS
|
+$640M |
| 4 |
Nasdaq
NDAQ
|
+$561M |
| 5 |
T-Mobile US
TMUS
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Consumer Discretionary | 1.3% |
| 3 | Financials | 1.2% |
| 4 | Healthcare | 1.11% |
| 5 | Industrials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9726
Bassett Furniture
BSET
$167M
| $168K | ﹤0.01% |
+10,710
| New | +$179K |
|
|
LITS
9727
CALL
Lite Strategy Inc
LITS
$30.7M
| $167K | ﹤0.01% |
+69,200
| New | +$285K |
|
9728
PUT
Vermilion Energy
VET
$1.78B
| $167K | ﹤0.01% |
21,400
+500
| +2% | +$3.86K |
|
9729
ProKidney
PROK
$286M
| $167K | ﹤0.01% |
68,993
-522,695
| -88% | -$1.39M |
|
|
AHRT
9730
PUT
AH Realty Trust
AHRT
$500M
| $167K | ﹤0.01% |
+23,800
| New | +$169K |
|
9731
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$6.13M
| $167K | ﹤0.01% |
10,149
+2,974
| +41% | +$56.5K |
|
9732
CALL
Trevi Therapeutics
TRVI
$2.62B
| $167K | ﹤0.01% |
18,200
-29,400
| -62% | -$220K |
|
9733
Humacyte
HUMA
$156M
| $167K | ﹤0.01% |
95,702
+38,560
| +67% | +$75.5K |
|
9734
CALL
Laser Photonics
LASE
$74.3M
| $166K | ﹤0.01% |
+38,600
| New | +$125K |
|
|
HIX
9735
Western Asset High Income Fund II
HIX
$355M
| $166K | ﹤0.01% |
38,240
+23,901
| +167% | +$103K |
|
9736
Epsilon Energy
EPSN
$167M
| $166K | ﹤0.01% |
32,962
+21,681
| +192% | +$131K |
|
|
SUIG
9737
CALL
Sui Group Holdings
SUIG
$64.5M
| $166K | ﹤0.01% |
+43,000
| New | +$194K |
|
9738
Beam Global
BEEM
$25.8M
| $166K | ﹤0.01% |
+57,566
| New | +$140K |
|
9739
SELLAS Life Sciences
SLS
$2.61B
| $166K | ﹤0.01% |
102,959
+56,277
| +121% | +$100K |
|
|
PDM
9740
CALL
Piedmont Realty Trust
PDM
$1.16B
| $166K | ﹤0.01% |
18,400
+1,700
| +10% | +$13.7K |
|
|
EVN
9741
Eaton Vance Municipal Income Trust
EVN
$433M
| $166K | ﹤0.01% |
+14,959
| New | +$159K |
|
9742
PUT
ProShares Short Real Estate
REK
$11.8M
| $166K | ﹤0.01% |
10,000
| – | – |
|
9743
Kimbell Royalty Partners
KRP
$1.5B
| $165K | ﹤0.01% |
12,249
-12,442
| -50% | -$175K |
|
9744
Escalade
ESCA
$280M
| $165K | ﹤0.01% |
+13,117
| New | +$168K |
|
|
ADFI
9745
DELISTED
Anfield Dynamic Fixed Income ETF
ADFI
| $165K | ﹤0.01% |
19,164
-15,315
| -44% | -$131K |
|
|
ATYR
9746
aTyr Pharma
ATYR
$51.2M
| $164K | ﹤0.01% |
227,785
+191,362
| +525% | +$867K |
|
|
NIU
9747
Niu Technologies
NIU
$161M
| $164K | ﹤0.01% |
34,996
+6,626
| +23% | +$27K |
|
9748
Biomea Fusion
BMEA
$98.6M
| $164K | ﹤0.01% |
81,216
-28,376
| -26% | -$52K |
|
9749
Gran Tierra Energy
GTE
$326M
| $164K | ﹤0.01% |
37,709
-11,612
| -24% | -$49.2K |
|
9750
Regencell Bioscience
RGC
$2.56B
| $164K | ﹤0.01% |
+10,616
| New | +$152K |
|
Similar funds
Jane Street's Q3 2025 Portfolio in Review
As of Q3 2025, Jane Street held 12,194 positions worth $657B, up 30% from $506B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $82.2B of net new capital in Q3 2025, opening 2,712 new positions and adding to 4,395 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 3,719,407 shares worth $251M.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Dell, an estimated $851M trimmed.
- Jane Street's largest Q3 2025 buy was iShares MSCI Emerging Markets ex China ETF: 3,719,407 shares worth $251M.
- Jane Street added most to NVIDIA in Q3 2025, an estimated $2.07B increase.
- Jane Street's biggest Q3 2025 reduction was Dell, cutting an estimated $851M.
- Jane Street fully exited iShares Core US Aggregate Bond ETF in Q3 2025, selling an estimated $441M.
- Jane Street's ten largest holdings make up 36% of its $657B portfolio in Q3 2025.
- Jane Street opened 2,712 new positions and closed 1,541 in Q3 2025.
- Jane Street's portfolio value rose 30% quarter-over-quarter to $657B.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.